1H-咪唑,1-丁基-5-苯基- | 116146-12-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1H-咪唑,1-丁基-5-苯基-
• 英文名称: 1-n-butyl-5-phenylimidazole
• 英文别名: 1-butyl-5-phenylimidazole
• CAS: 116146-12-4
• 化学式: C₁₃H₁₆N₂
• 分子量: 200.283
• InChiKey: NBUPUMFFQRMLFZ-UHFFFAOYSA-N

物化性质

• 沸点：
  378.7±11.0 °C(Predicted)
• 密度：
  1.00±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  N-[(E)-2-phenyl-1-(toluene-4-sulfonyl)-vinyl]-formamide 在 三乙胺 、 三氯氧磷 作用下， 以 甲醇 、 乙二醇二甲醚 为溶剂， 反应 1.0h， 生成 1H-咪唑,1-丁基-5-苯基-
  参考文献：
  名称：

  Kikuchi, Masamichi; Kuwano, Eiichi; Nakashima, Yukiko, Bioscience, Biotechnology and Biochemistry, 1992, vol. 56, # 1, p. 161 - 162

  摘要：

  DOI：

文献信息

• Palladium-Catalyzed Arylation of Electron-Rich Heterocycles with Aryl Chlorides
  作者：Hendrich A. Chiong、Olafs Daugulis

  DOI：10.1021/ol0702324

  日期：2007.4.1

  [reaction: see text] Palladium-catalyzed C-H activation: cheap aryl chlorides can now be used for the arylation of a wide variety of electron-rich heterocycles. The key to the success of this reaction is the use of a bulky, electron-rich phosphine ligand. No copper additives are needed.

  [反应：见正文]钯催化的CH活化：廉价的芳基氯化物现在可用于多种电子富集的杂环的芳基化。该反应成功的关键是使用庞大的富含电子的膦配体。不需要铜添加剂。
• USE OF ARYL CHLORIDES IN PALLADIUM-CATALYZED C-H BOND FUNCTIONALIZATION
  申请人：Daugulis Olafs

  公开号：US20090012293A1

  公开（公告）日：2009-01-08

  A one-step method for efficiently converting carbon-hydrogen bonds into carbon-carbon bonds using chloroarenes and palladium catalysts is disclosed. This method allows faster introduction of complex molecular entities, a process that would otherwise require many more steps. This invention is particularly relevant for the organic synthesis of complex molecules such as, but not limited to, pharmacophores.

  一种将氯代芳烃和钯催化剂高效地将碳氢键转化为碳碳键的一步法方法被揭示。该方法可以更快地引入复杂的分子实体，而这个过程通常需要更多的步骤。这一发明特别适用于有机合成复杂分子，例如但不限于药用分子。
• IDO Inhibitors
  申请人：Mautino Mario R.

  公开号：US20110136796A1

  公开（公告）日：2011-06-09

  Presently provided are compounds according to the formula (I) or (II), and pharmaceutical compositions comprising the compounds, wherein R 1 , R 4 , and R 5 are defined herein. Such compounds and compositions are useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine -2,3-dioxygenase; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immunosuppression associated with cancer; and treating immunosupression associated with an infectious disease.

  目前提供了按照公式(I)或(II)定义的化合物以及含有这些化合物的药物组合物，其中R1、R4和R5的定义在此处。这些化合物和组合物对于调节吲哚胺2,3-二氧化酶的活性；治疗吲哚胺2,3-二氧化酶(IDO)介导的免疫抑制；治疗从抑制吲哚胺-2,3-二氧化酶的酶活性中获益的医疗状况；增强包括给予抗癌剂的抗癌治疗的有效性；治疗与癌症相关的肿瘤特异性免疫抑制；以及治疗与传染性疾病相关的免疫抑制具有用处。
• Preparation of Sterically More Crowded 1,5-Disubstituted Imidazoles by the Regioselective N-Alkylation
  作者：Choji Kashima、Yukari Harada、Akira Hosomi

  DOI：10.3987/com-92-s49

  日期：——

  4-Substituted 1-acetylimidazoles (6), which were derived from 4(5)-substituted imidazoles (1), were N-alkylated by the treatment with alkyl halides. During the work-up, the resulting N-alkylated products were easily hydrolyzed into 1,5-disubstituted imidazoles (3). These reactions were regarded to be the general method for the preparation of sterically more crowded 1,5-disubstituted imidazoles (3).
• IDO INHIBITORS
  申请人：Newlink Genetics

  公开号：EP2291187A2

  公开（公告）日：2011-03-09